Episode Details
Back to Episodes
#132 | What It Really Takes To Bring a Biotech Platform To Market
Published 10 months, 2 weeks ago
Description
Great science doesn’t guarantee commercial success - especially in biotech.
In this episode, Hakeem sits down with Nigel Theobald, founder and CEO of N4 Pharma, to unpack what it really takes to turn an RNA delivery platform into a viable, scalable business. From investor pressure to team building and tough pivots, Nigel shares lessons every biotech or MedTech founder needs to hear.
Here’s what you’ll learn:
– How to go from a biotech platform to a commercial product
– What it takes to build a virtual, world-class team in a capital-intensive space
– How to stay resilient when timelines shift and strategies evolve
If you're building something at the edge of science and business - this episode is for you.